BNTC vs LRMR
Comparison between Benitec Biopharma Inc (BNTC, Company) and Larimar Therapeutics Inc (LRMR, Company).
Both BNTC and LRMR are from the Healthcare sector.
5-Year PerformanceLRMR has outperformed BNTC, delivering a return of -16.1% compared to -32.5%
BNTC vs LRMR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BNTC vs LRMR - Historical Returns
Returns include dividend reinvestment.
BNTC vs LRMR - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | BNTC | LRMR |
|---|---|---|
| 2026 | -11.16% | +0.00% |
| 2025 | +11.51% | -4.99% |
| 2024 | +286.01% | -24.27% |
| 2023 | +8.57% | +13.75% |
| 2022 | -93.80% | -61.58% |
| 2021 | -21.56% | -50.95% |
| 2020 | -56.99% | +60.74% |
| 2019 | -66.00% | -78.06% |
| 2018 | -48.39% | +3.34% |
| 2017 | +93.46% | +42.59% |
| 2016 | -63.48% | -50.23% |
| 2015 | -49.56% | -79.66% |
| 2014 | N/A | +56.15% |
BNTC vs LRMR Drawdown Comparison
The maximum drawdown for BNTC was -99.91%, occurring on Aug 8, 2023. This drawdown has not yet recovered.
The maximum drawdown for LRMR was -99.75%, occurring on Aug 5, 2022. This drawdown has not yet recovered.
The current BNTC drawdown is -99.48%. The current LRMR drawdown is -99.44%.
| Rank | BNTC | LRMR |
|---|---|---|
| #1 | -99.91% Aug 20, 2015 - Aug 8, 2023 | -99.75% Mar 19, 2015 - Aug 5, 2022 |
| #2 | N/A | -22.18% Sep 2, 2014 - Oct 30, 2014 |
| #3 | N/A | -16.93% Jan 8, 2015 - Jan 26, 2015 |
| #4 | N/A | -12.88% Jun 23, 2014 - Aug 28, 2014 |
| #5 | N/A | -12.79% Oct 30, 2014 - Nov 24, 2014 |
| #6 | N/A | -11.17% Jan 27, 2015 - Feb 23, 2015 |
| #7 | N/A | -10.00% Feb 23, 2015 - Mar 10, 2015 |
| #8 | N/A | -8.22% Nov 28, 2014 - Dec 17, 2014 |
| #9 | N/A | -3.27% Dec 26, 2014 - Jan 6, 2015 |
| #10 | N/A | -1.18% Mar 12, 2015 - Mar 16, 2015 |
| #11 | N/A | -0.99% Aug 28, 2014 - Sep 2, 2014 |
Correlation
Correlation between BNTC and LRMR is 0.87 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks